The @alzassociation just launched the Brain Health & Quality Care Initiative to help clinicians and health systems put advances into everyday practice, starting in primary care. Explore the initiative: alz.org/BHQCI
ALZPro retweeted
Dementia science investigators & researchers: submit your brain health related manuscripts & bring your voice to this accelerating topic in dementia science. Visit the new @alzdemjournals brain health section to learn how you can contribute your work: alz-journals.onlinelibrary.w…
ALZPro retweeted
Explore the latest issue of #TRCI for key takeaways from the spring 2025 @alzassociation Research Roundtable on advances in biomarkers, prevention & treatment approaches before cognitive symptoms #AlzResearch
alz-journals.onlinelibrary.w…
ALZPro retweeted
Applications are now open for IMPACT-AD 2026!
Led by Dr. Rema Raman and Dr. Joshua Grill, #IMPACTAD trains the next generation of leaders in Alzheimer’s disease and related dementias clinical trials.
Apply here: na2.hubs.ly/H04w0Pc0
ALZPro retweeted
We’ve earned Joint Accreditation for Interprofessional Continuing Education, enabling training for entire health care teams through a unified process—advancing brain health, early detection and high-quality dementia care nationwide. bit.ly/44ZX4L9
#BrainHealth #DementiaCare #HealthCareQuality #ContinuingEducation
ALZPro retweeted
Research update 🔬: The evoke and evoke+ clinical trials testing an oral semaglutide pill (GLP-1 drug) to treat early Alzheimer’s did not demonstrate a statistically significant reduction in disease progression.
While we are disappointed in the results, these studies provide valuable insights that will guide future research into new, non-amyloid treatment approaches.
Read our full statement: bit.ly/3M0OTaH.
ALZPro retweeted
Health care professionals: thank you for attending AAIC For All to hear the latest in Alzheimer’s treatment, prevention and care.
➡️ Next up: Explore ALZPro—the Association’s new hub that centralizes the tools you need. alz.org/ALZPro #AAIC25
@ALZ_Pro







